URIVIB T DUTASTERIDE 0.5mg. IP + TAMSULOSIN 0.4mg. IP

Urivib T tablets combine dutasteride and tamsulosin for treating symptomatic benign prostatic hyperplasia in men with an enlarged prostate. Main uses: treatment of symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate; relief of urinary symptoms linked to an enlarged prostate, such as a weak stream and difficulty in passing urine; helps improve BPH symptoms by reducing prostate enlargement and relaxing the prostate and bladder neck.

Common side effects of Urivib T Tablet include ejaculation disorders; impotence; decreased libido; dizziness; breast disorders, including breast enlargement and breast tenderness. Get medical help at once if you notice sudden drop in blood pressure on standing (orthostatic hypotension) or fainting; severe allergic reactions such as swelling of the face, lips or throat (angioedema), urticaria, itching or breathing difficulty; A confirmed rise in PSA while on this medicine may signal prostate cancer and must be evaluated by a doctor.

Each Urivib T tablet contains Dutasteride 0.5 mg + Tamsulosin 0.4 mg. The right dose and how long to take it depend on the condition, age and other medicines, so use Urivib T Tablet only as your doctor advises.

The MRP of Urivib T Tablet is ₹197 for a pack of 10x10 (Alu Alu). For chemists and distributors, the PTR is ₹150.1 and the PTS is ₹135.09.

Each Urivib T tablet contains Dutasteride 0.5 mg + Tamsulosin 0.4 mg. It comes in a pack of 10x10 (Alu Alu).

Two ingredients work in different ways to help BPH symptoms. Dutasteride blocks both forms of the 5-alpha-reductase enzyme, which slows the change of testosterone into DHT, the hormone mainly behind prostate enlargement. Tamsulosin acts on alpha 1A-adrenoreceptors and relaxes the smooth muscle of the prostate and bladder neck, so urine passes more easily. Together, they address both the size of the gland and the tightness around the outlet.

Must not be used in females who are pregnant, as dutasteride can harm the male foetus. Must not be used by anyone with a previous serious allergic reaction (skin reaction, angioedema, urticaria, itching, breathing difficulty) to dutasteride, other 5-alpha-reductase inhibitors, tamsulosin or any other component of the product. Must not be used with other alpha-adrenergic antagonists, as this may increase the risk of low blood pressure. Must not be used with strong CYP3A4 inhibitors such as ketoconazole. Check with a doctor first if you are taking moderate CYP3A4 inhibitors such as erythromycin or strong or moderate CYP2D6 inhibitors such as paroxetine, or if you feel dizzy or light-headed on standing, or if you have liver problems.

Urivib T Tablet is a brand of Vibcare Pharma, sold through its Genvimax division. It is available for PCD pharma franchise and distribution in India; use the Send Enquiry or WhatsApp button on this page to ask about availability and terms.